A retrospective study of SARS-CoV2 vaccination in Hungarian idiopathic pulmonary fibrosis patients
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Coronavirus vaccine-Wuhan Institute of Biological Products (Primary) ; COVID-19 vaccine-Gamaleya National Research Center of Epidemiology and Microbiology (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 07 Feb 2023 New trial record